Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 11, 1999, Pages 2598-2607

  Bodaghi, Bahram ^a,c   Slobbe Van Drunen, Marlea E P ^d   Topilko, Andrzei ^a   Perret, Emmanuelle ^a   Vossen, Renée C R M ^d   Van Dam Mieras, Maria C E ^b   Zipeto, Donato ^a   Virelizier, Jean Louis ^a   LeHoang, Phuc ^c   Bruggeman, Cathrien A ^d   Michelson, Susan ^a  

^a INSTITUT PASTEUR   (France)

^b OPEN UNIVERSITY OF THE NETHERLANDS   (Netherlands)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHALASIN B; VISUAL PIGMENT;

ARTICLE; CYTOMEGALOVIRUS INFECTION; ENDOCYTOSIS; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PIGMENT CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

AMMONIUM CHLORIDE; CELL MEMBRANE; CELLS, CULTURED; CHLOROQUINE; CYTOCHALASIN B; CYTOMEGALOVIRUS; ENDOCYTOSIS; ENDOTHELIUM, VASCULAR; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MEMBRANE FUSION; PIGMENT EPITHELIUM OF EYE; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0032850968     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Myerson D, Hackman RC, Nelson JA, Ward DC, McDougall JK. Widespread presence of histologically occult cytomegalovirus. Hum Pathol. 1984;15:430-439.
2. Stals FS, Bosman F, van Boven CP, Bruggeman CA. An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host. Arch Virol. 1990;114:91-107.
3. Sinzger C, Jahn G. Human cytomegalovirus cell tropism and pathogenesis. Intervirology. 1996;39:302-319.
4. Sinzger C, Plachter B, Grefte A, The TH, Jahn G. Tissue macrophages are infected by human cytomegalovirus in vivo. J Infect Dis. 1996;173:240-245.
5. Sinclair J, Sissons P. Latent and persistent infections of monocytes and macrophages. Intervirology, 1996;39:293-301.
6. Grefte A, Blom N, van der Giessen M, van Son W, The TH. Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: evidence for virus production and endothelial origin. J Infect Dis. 1993;168:1110-1118.
7. Hendrix M, Dormans P, Kitslaar P, Bosman F, Bruggeman C. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am J Pathol. 1989:134:1151-1157.
8. Hendrix MG, Daemen M, Bruggeman CA. Cytomegalovims nucleic acid distribution within the human vascular tree. Am J Pathol. 1991:138:563-567.
9. Henderly DE, Atalla LR, Freeman WR, Rao NA. Demonstration of cytomegalovirus retinitis by in situ DNA hybridization. Retina. 1988;8:177-181.
10. Miceli MV, Newsome DA, Novak LC, Beuerman RW. Cytomegalovirus replication in cultured human retinal pigment epithelial cells. Curr Eye Res. 1989;8:835-839.
11. Rao NA, Zhang J, Ishimoto S. Role of retinal vascular endothelial cells in development of CMV retinitis. Trans Am Ophthalmol. Soc. 1998:96:111-123.
12. Hendrix MG, Wagenaar M, Slobbe RL, Bruggeman CA. Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J Clin Pathol. 1997:50:59-63.
13. Vossen RC, van Dam-Mieras MC, Bruggeman CA. Cytomegalovirus infection and vessel wall pathology. Intervirology. 1996;39:213-221.
14. Vossen RC, Derhaag JG, Slobbe-van Drunen ME, Duijvestijn AM, van Dam-Mieras MC, Bruggeman CA. A dual role for endothelial cells in cytomegalovirus infection? A study of cytomegalovirus infection in a series of rat endothelial cell lines. Virus Res. 1996; 46:65-74.
15. Tumilowicz JJ. Characteristics of human arterial smooth muscle cell cultures infected with cytomegalovirus. In Vitro Cell Dev Biol. 1990:26:1144-1150.
16. Slobbe-van Drunen ME, Vossen RC, Couwenberg FM, et al. Activation of protein kinase C enhances the infection of endothelial cells by human cytomegalovirus. Virus Res. 1997:48:207-213.
17. Vossen RC, Persoons MC, Slobbe-van Drunen ME, Bruggeman CA, van Dam-Mieras MC. Intracellular thiol redox status affects rat cytomegalovirus infection of vascular cells. Virus Res. 1997;48: 173-183.
18. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol. 1991;72:2059-2064.
19. Waldman WJ, Knight DA, Huang EH, Sedmak DD. Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model. J Infect Dis. 1995:171:263-272.
20. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine: The Zidovudine Epidemiology Study Group. J Infect Dis. 1992;166:1223-1227.
21. Hoover DR, Peng Y, Saah A, et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch Ophthalmol. 1996:114:821-827.
22. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107: 75-80.
23. Bok D. The retinal pigment epithelium: a versatile partner in vision. J Cell Sci Suppl. 1993:17:189-195.
24. Detrick B, Rhame J, Wang Y, Nagineni CN, Hooks JJ. Cytomegalovirus replication in human retinal pigment epithelial cells: altered expression of viral early proteins. Invest Ophthalmol Vis Sci. 1996:37:814-825.
25. Slobbe-van Drunen ME, Hendrickx AT, Vossen RC, Speel EJM, van Dam-Mieras MC, Bruggeman CA. Nuclear import as a barrier for infection of endothelial cells with human cytomegalovirus. Virus Res. 1998;56:149-156.
26. Marsh M, Helenius A. Virus entry into animal cells. Adv Virus Res. 1989;36:107-151.
27. Carlson C, Britt WJ, Compton T. Expression, purification, and characterization of a soluble form of human cytomegalovirus glycoprotein B. Virology. 1997;239:198-205.
28. Hernandez LD, Hoffman LR, Wolfsberg TG, White JM. Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol. 1996;12:627-661.
29. Bukrinskaya AG. Penetration of viral genetic material into host cell. Adv Virus Res. 1982;27:141-204.
30. Wittels M, Spear PG. Penetration of cells by herpes simplex virus does not require a low pH-dependent endocytic pathway. Virus Res. 1991;18:271-290.
31. Compton T, Nepomuceno RR, Nowlin DM. Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology. 1992;191:387-395.
32. Topilko A, Michelson S. Hyperimmediate entry of human cytomegalovirus virions and dense bodies into human fibroblasts. Res Virol. 1994;145:75-82.
33. Nemerow GR, Cooper NR. Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process. Virology. 1984;132:186-198.
34. Miller N, Hutt-Fletcher LM. Epstein-Barr virus enters B cells and epithelial cells by different routes. J Virol. 1992;66:3409-3414.
35. Pozzi D, Zompetta C, Faggioni A, et al. Early events of fusion between Epstein Barr virus and human lymphoblastoid cells (Raji) detected by R18 fluorescence dequenching measurements. Membrane Biochem. 1990;9:239-251.
36. Lisi A, Pozzi D, Carloni G, et al. Fusion of EBV with the surface of receptor-negative human hepatoma cell line Li7A permits virus penetration and infection. Res Virol. 1995;146:295-300.
37. Nash M, Osborne N. Pertussis toxin-sensitive melatonin receptors negatively coupled to adenylate cyclase associated with cultured human and rat retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1995;36:95-102.
38. Alcami J, Paya CV, Virelizier JL, Michelson S. Antagonistic modulation of human cytomegalovirus replication by transforming growth factor beta and basic fibroblastic growth factor. J Gen Virol. 1993:74:269-274.
39. Ho WZ, Cherukuri R, Ge SD, et al. Centrifugal enhancement of human immunodeficiency virus type 1 infection and human cytomegalovirus gene expression in human primary monocyte/macrophages in vitro. J Leukoc Biol. 1993:53:208-212.
40. Amadei C, Tardy-Panit M, Couillin P, et al. Kinetic study of the developement and localization of human cytomegalovirus-induced antigens using monoclonal antibodies. Ann Virol. 1983:134:165-181.
41. Mazeron MC, Jahn G, Plachter B. Monoclonal antibody E-13 (M-810) to human cytomegalovirus recognizes an epitope encoded by exon 2 of the major immediate early gene. J Gen Virol. 1992;73: 2699-2703.
42. Shimura H, Umeno Y, Kimura G. Effects of inhibitors of the cytoplasmic structures and functions on the early phase of infection of cultured cells with simian virus 40. Virology. 1987:158:34-43.
43. Michelson-Fiske S, Horodniceanu F, Guillon JC. Immediate early antigens in human cytomegalovirus infected cells. Nature. 1977; 270:615-617.
44. Baldick CJ, Marchini A, Patterson CE, Shenk T. Human cytomegalovirus tegument protein Pp71 (Ppul82) enhances the infectivity of viral DNA and accelerates the infectious cycle. J Virol. 1997;71: 4400-4408.
45. Topilko A, Michelson S. Morphological and cytochemical analysis of human cytomegalovirus inoculum: correlation of free particles in inoculum with counterparts in infected cells. Res Virol. 1994; 145:65-73.
46. Hall MO, Abrams T. Kinetic studies of rod outer segment binding and ingestion by cultured rat RPE cells. Exp Eye Res. 1987:45:907-922.
47. Mallard F, Antony A, Tenza D, Salamero J, Goud B, Johannes L. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of Chiga toxin B-fragment transport. J Cell Biol. 1998;143:973-990.
48. Gibson W. Protein counterparts of human and simian cytomegaloviruses. Virology. 1983;128:391-406.
49. Greber UF, Singh I, Helenius A. Mechanisms of virus uncoating. Trends Microbiol. 1994;2:52-56.
50. Kielian M, Jungerwirth S. Mechanisms of enveloped virus entry into cells. Mol Biol Med. 1990;7:17-31.
51. Kock J, Borst EM, Schlicht HJ. Uptake of duck hepatitis B virus into hepatocytes occurs by endocytosis but does not require passage of the virus through an acidic intracellular compartment. J Virol. 1996;70:5827-5831.
52. Irurzun A, Nieva JL, Carrasco L. Entry of Semliki forest virus into cells: effects of concanamycin A and nigericin on viral membrane fusion and infection. Virology. 1997;227:488-492.
53. Marsh M, Kielian MC, Helenius A. Semliki forest virus entry and the endocytic pathway. Biochem Soc Transac. 1984;12:981-983.
54. Yoshimura A, Ohnishi S. Uncoating of influenza virus in endosomes. J Virol. 1984;51:497-504.
55. Bishop NE. An update on non-clathrin-coated endocytosis. Rev Med Virol. 1997;7:199-209.
56. Schmolke S, Kern HF, Drescher P, Jahn G, Plachter B. The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J Virol. 1995;69:5959-5968.
57. Dal Monte P, Bessia C, Ripalti A, et al. Stably expressed antisense RNA to cytomegalovirus UL83 inhibits viral replication. J Virol. 1996;70:2086-2094.
58. Pomerantz RJ, Kuritzkes DR, de la Monte SM, et al. Infection of the retina by human immunodeficiency virus type I. N Engl J Med. 1987:317:1643-1647.
59. Skolnik PR, Pomerantz RJ, de la Monte SM, et al. Dual infection of retina with human immunodeficiency virus type 1 and cytomegalovirus. Am J Ophthalmol. 1989:107:361-372.
60. Burd EM, Pulido JS, Puro DG, O'Brien WJ. Replication of human cytomegalovirus in human retinal glial cells. Invest Ophthalmol Vis Sci. 1996;37:1957-1966.
61. Pleskoff O, Treboute C, Alizon M. The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins. J Virol. 1998;72:6389-6397.
62. Zipeto D, Bodaghi B, Laurent L, Virelizier J-L, Michelson S. Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types. J Gen Virol. 1999;80:543-547.